Copy of Associate Scientist, Gene Editing and iPSC Engineering at Eurofins

Boston, Massachusetts, United States -

Full Time

Start Date

Immediate

Expiry Date

04 Feb, 26

Salary

41.0

Posted On

06 Nov, 25

Experience

2 year(s) or above

Remote Job

Yes

Telecommute

Yes

Sponsor Visa

Skills

Gene Editing, iPSC Engineering, CRISPR, Cell Line Development, Molecular Characterization, dPCR, qPCR, Flow Cytometry, Molecular Biology, Assay Development, GMP, Experimental Records, SOP Development, Cell Culture, Pancreatic Islet Differentiation, Electronic Lab Notebooks

Industry

Medical and Diagnostic Laboratories

Description

Company Description At Eurofins PSS, we believe the work we do matters, from supporting life-saving therapies to fostering scientific innovation. As part of Eurofins Scientific, a global leader in analytical testing, we offer a unique opportunity to grow your career in the biopharmaceutical industry while enjoying work-life balance, professional development, and a competitive benefits package. Job Description We are seeking a driven and detail-oriented Associate Scientist to join our diabetes-focused team. This lab-based role centers on advancing gene editing and iPSC engineering to support the development of next-generation islet cell therapies. The ideal candidate will bring hands-on expertise in CRISPR-based gene editing, cell line development, and molecular characterization techniques, including dPCR/qPCR and flow cytometry. Key Responsibilities Execute and optimize CRISPR-based gene editing workflows in human iPSCs. Develop and characterize clonal cell lines using flow cytometry, dPCR, and qPCR. Perform routine iPSC culture, passaging, and differentiation into pancreatic islet cells. Support assay development for on-/off-target analysis using PCR and NGS. Collaborate cross-functionally to support assay transfer from R&D to GMP environments. Maintain detailed experimental records and contribute to SOP development. Participate in rotational weekend support for cell culture activities. Qualifications Required Qualifications B.S. with 3–4 years or M.S. with 1–2 years of relevant industry experience in gene editing and cell therapy. Proven experience with: CRISPR-based gene editing Cell line development dPCR or qPCR Flow cytometry Strong molecular biology skills, including construct design and PCR-based analysis. Excellent communication, organizational, and documentation skills. Preferred Qualifications Experience with pancreatic islet differentiation. Familiarity with GMP transitions and electronic lab notebooks (ELNs). Authorization to work in the U.S. without restriction or sponsorship. Additional Information The position is Fulltime, Monday through Friday, 8am-5pm, with occasional weekends (on a rotational basis to support cell culture). Candidates currently living within a commutable distance of Boston, MA, are encouraged to apply. What to Expect in the Hiring Process: 10-15 Minute Phone Interview with Region Recruiter 45-60 Minute Virtual Interview with Manager and/or Group Leader 45-60 Minute In-Person Meeting over Coffee for a Casual Discussion of the Role What We Offer: Target pay range: $37-41/hr Excellent full-time benefits, including comprehensive medical coverage, dental, and vision options Life and disability insurance 401(k) with company match Paid vacation and holidays Yearly goal-based bonus & eligibility for merit-based increases Ready to Make an Impact? If you're passionate about advancing cell therapy and gene editing technologies and want to be part of a collaborative, mission-driven team, we encourage you to apply today. Join us in shaping the future of regenerative medicine—your next scientific breakthrough starts here. Eurofins USA PSS Insourcing Solutions is a Disabled and Veteran Equal Employment Opportunity employer.

Responsibilities

The Associate Scientist will execute and optimize CRISPR-based gene editing workflows in human iPSCs and develop and characterize clonal cell lines. They will also support assay development and collaborate cross-functionally to transfer assays from R&D to GMP environments.